---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-230283"
form_type: "8-K"
ticker: "INAB"
cik: "0001740279"
company_name: "IN8BIO, INC."
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-30T23:33:33.513026+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# IN8bio raises $12.4M in private placement; amends Series A warrants

## Summary
- Gross proceeds of ~$12.4M from sale of units at $0.3950 per unit; closing expected Oct 4, 2024.
- Units consist of common stock or pre-funded warrants plus Series C warrants (exercise price $0.27, 3-year term).
- Series A warrants amended: exercise price reduced from $1.25 to $0.45, term extended by one year from closing.
- Company to file resale registration statement within 30 days of closing.
- Funds expected to support operating plan into 2026.

## SEC filing metadata
- accession: 0001193125-24-230283
- form_type: 8-K
- ticker: INAB
- cik: 0001740279
- company_name: IN8BIO, INC.
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740279/000119312524230283/0001193125-24-230283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740279/000119312524230283/d895981d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-230283
- JSON: https://secwatch.observer/filing/0001193125-24-230283.json
- Plain text: https://secwatch.observer/filing/0001193125-24-230283.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.